Medication info

Nucomit Liquid (Acetylcysteine)

OTC medicationSolutionExternal use
Ingredient · strength
Acetylcysteine›200mg / 1mL
Manufacturer / importer
(Co., Ltd.) Celltrion Pharm
Appearance
A colorless and transparent liquid contained in a colorless and transparent ampoule
Packaging
10 ampoules (1 ampoule/4mL * 10 pieces)
Approval status
Active

MFDS item code 198600267 · Notified 1986.04.22 · Insurance code 693900211

Summary

Main use
Relief of difficulty expectorating sputum (such as in asthma and pneumonia), and peri-procedural management and treatment for bronchial examinations and similar procedures
Who uses it
Adults
Adult use
This drug may be diluted to a lower concentration using Sodium Chloride Injection, Sodium Chloride Inhalation Solution, Sterile Water for Injection, or Sterile Water for Inhalation. 1. Nebulization using a face mask, mouthpiece, or tracheostomy: Nebulize 1 ~ 10 mL of this drug every 2 ~ 6 hours. The recommended amount is 3~ 5 mL, nebulized 3 ~ 4 times daily. 2. Nebulization using a nebulizer tent or inhaler (Croupette): This method is needed in special cases and should be used individually according to the patient's needs and the convenience of the administration method. This method requires a large volume of solution, sometimes up to approximately 300 mL per treatment. The recommended amount should be sufficient to maintain a very dense, mist-like atmosphere in the tent or inhaler throughout the treatment period. Intermittent or continuous administration over an extended period is recommended. 3. Direct instillation 1) Administer 1 ~ 2 mL of this drug every hour. 2) For routine treatment of patients with a tracheostomy, administer 1 ~ 2 mL of this drug through the tracheostomy every 1 ~ 4 hours. 3) For direct administration to a specific part of the bronchial tree by inserting a small plastic catheter into the trachea under local anesthesia and direct incision, administer 2 ~ 5 mL of this drug every 1 ~ 4 hours using a syringe connected to the catheter. 4) When administering via a percutaneous endobronchial catheter, administer 1 ~ 2 mL of this drug every 1 ~ 4 hours using a syringe connected to the catheter. 4. Diagnostic bronchography Before performing bronchography, administer 1 ~ 2 mL of this drug by nebulization 2 ~ 3 times or by intrabronchial instillation.

Ingredients

Manufacturer
(Co., Ltd.) Celltrion Pharm

Efficacy & effects

Relief of difficulty expectorating sputum (such as in asthma and pneumonia), and peri-procedural management and treatment for bronchial examinations and similar procedures

  • Difficulty in expectoration
  • bronchial asthma
  • chronic bronchitis
  • bronchiectasis
  • pulmonary tuberculosis
  • emphysema
  • upper respiratory tract inflammation
  • pharyngitis
  • lung abscess
  • pneumonia
  • cystic fibrosis
  • postoperative pulmonary complications
View approved original text

This medication is used to relieve symptoms of difficulty in expectoration in respiratory diseases such as bronchial asthma, chronic bronchitis, and pneumonia. It also helps in pre- and post-procedures and surgeries related to the bronchi, such as bronchography, bronchoscopy, lung cancer cytological examinations, and tracheostomy. This helps improve respiratory health and effectively manage symptoms.

How to use

Adult use

This drug may be diluted to a lower concentration using Sodium Chloride Injection, Sodium Chloride Inhalation Solution, Sterile Water for Injection, or Sterile Water for Inhalation. 1. Nebulization using a face mask, mouthpiece, or tracheostomy: Nebulize 1 ~ 10 mL of this drug every 2 ~ 6 hours. The recommended amount is 3~ 5 mL, nebulized 3 ~ 4 times daily. 2. Nebulization using a nebulizer tent or inhaler (Croupette): This method is needed in special cases and should be used individually according to the patient's needs and the convenience of the administration method. This method requires a large volume of solution, sometimes up to approximately 300 mL per treatment. The recommended amount should be sufficient to maintain a very dense, mist-like atmosphere in the tent or inhaler throughout the treatment period. Intermittent or continuous administration over an extended period is recommended. 3. Direct instillation 1) Administer 1 ~ 2 mL of this drug every hour. 2) For routine treatment of patients with a tracheostomy, administer 1 ~ 2 mL of this drug through the tracheostomy every 1 ~ 4 hours. 3) For direct administration to a specific part of the bronchial tree by inserting a small plastic catheter into the trachea under local anesthesia and direct incision, administer 2 ~ 5 mL of this drug every 1 ~ 4 hours using a syringe connected to the catheter. 4) When administering via a percutaneous endobronchial catheter, administer 1 ~ 2 mL of this drug every 1 ~ 4 hours using a syringe connected to the catheter. 4. Diagnostic bronchography Before performing bronchography, administer 1 ~ 2 mL of this drug by nebulization 2 ~ 3 times or by intrabronchial instillation.

Precautions

This drug should not be taken by anyone who has an allergic reaction to this drug or its components. Those with ulcers in the stomach or duodenum and children under the age of 2 should also avoid use. Women who are pregnant or may become pregnant should only take it after consulting with a doctor. Nursing mothers should be cautious about taking this medication due to uncertainty whether it passes into breast milk. If symptoms such as nausea, vomiting, inflammation of the mouth, heartburn, or diarrhea occur during use, discontinue use immediately and consult a specialist. If allergic symptoms such as hives, itching, rash, headache, tinnitus, or dyspnea occur, cease use immediately and consult a doctor. This medication may reduce the efficacy of certain antibiotics, so it is advisable to take it with an interval of at least 2 hours from the antibiotics. Avoid mixing other medications into this drug solution. Store out of reach of children, and keep in the original container to prevent misuse or quality degradation. Caution is required when the inhalation formulation is used by patients with bronchial asthma or impaired respiratory function, as bronchospasm may occur. The safety of the inhalation formulation has not been established in elderly patients or children, and should only be used after consulting a specialist. Observational monitoring may be necessary as mild drowsiness, nausea, vomiting, and loss of appetite can occasionally occur after inhalation. If bronchial secretions increase and cannot be naturally expelled, mechanical methods or position changes should be used to assist. The inhalation formulation may reduce the effectiveness of antibiotics, so they should be taken separately or by other means of administration. This medication should not be used as an injection or eye drop; after using a nebulizer, it is recommended to wash the face mask with water to remove its residue. Nebulizer parts must be cleaned immediately after use to prevent corrosion or blockages due to leftover medication. The nebulized solution may become more concentrated over time, so it is safer and more effective to use it diluted.

Side effects

  • Nausea
  • vomiting
  • stomatitis
  • heartburn
  • diarrhea
  • urticaria
  • itching
  • rash
  • headache
  • tinnitus
Show 15 more
  • bronchospasm
  • tachycardia
  • hypertension
  • anaphylaxis
  • dyspnea
  • bronchial obstruction
  • mild intoxication
  • loss of appetite
  • hemoptysis
  • chills
  • fever
  • rhinitis
  • drowsiness
  • chest tightness
  • irritation of the trachea and bronchi

Not everyone experiences these, and they can vary from person to person.

Interactions

Drug interactions

This medication should be discussed with a doctor or pharmacist if taken with antibiotics, tetracycline, erythromycin, bromhexine, and other substances.

Storage

This medication should be stored in a sealed container to prevent exposure to air and is best kept at room temperature between 1 to 30 degrees Celsius. Additionally, it is important to avoid direct sunlight and store in a dark place to maintain the drug's efficacy.

Appearance and packaging

Appearance

A colorless and transparent liquid contained in a colorless and transparent ampoule

Package unit

10 ampoules (1 ampoule/4mL * 10 pieces)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.